Santiago de Cuba, Feb 26 (Prensa Latina) The Cuban medication Heberprot-P for diabetic feet ulcers is becoming increasingly accepted in a number of countries, according to Dr. Luis Herrera Martinez, director of the Genetic Engineering and Biotechnology Center CIGB).Herrera Martinez said Heberprot-P is the leading product of that institution, and it has been used to treat more than 22,000 patients in different countries, helping to avoid amputations and improve quality of life.">Santiago de Cuba, Feb 26 (Prensa Latina) The Cuban medication Heberprot-P for diabetic feet ulcers is becoming increasingly accepted in a number of countries, according to Dr. Luis Herrera Martinez, director of the Genetic Engineering and Biotechnology Center CIGB).Herrera Martinez said Heberprot-P is the leading product of that institution, and it has been used to treat more than 22,000 patients in different countries, helping to avoid amputations and improve quality of life.">

Cuba Headlines

Cuba News, Breaking News, Articles and Daily Information

Cuban Diabetic Foot Medication More Accepted Worldwide

  • Submitted by: manso
  • 02 / 27 / 2011


Santiago de Cuba, Feb 26 (Prensa Latina) The Cuban medication Heberprot-P for diabetic feet ulcers is becoming increasingly accepted in a number of countries, according to Dr. Luis Herrera Martinez, director of the Genetic Engineering and Biotechnology Center CIGB).

Herrera Martinez said Heberprot-P is the leading product of that institution, and it has been used to treat more than 22,000 patients in different countries, helping to avoid amputations and improve quality of life.

A clinical study was recently begun in Europe for a new health patent, and the drug has had good results in Venezuela, Dominican Republic, Algeria and Libya, among other nations, Herrera said.

Commercial processes with Russia, China and South Africa are going forward, and a Brazilian company is evaluating possibilities, he said.

The CIGB director added that the product was being monitored and showed safe results, with hardly any relapses among patients.

The use of Heberprot-P dates back to five years ago, and is promoted within the Cuban health system as a valid alternative for diabetic foot, a problem that is growing worldwide.

Related News

Comments